CARVEDILOL in pharma franchise in Himachal Pradesh

CARVEDILOL in PCD pharma franchise in Imphal

CARVEDILOL in top pharma company in Panaji

CARVEDILOL in pcd pharma supplier in Vasai-Virar

CARVEDILOL in phama franchise company in india
CARVEDILOL phama distributor in Pune

Home/Products /carvedilol-6-point-25-tablet

Cardistep 6.25 Tablet

Composition : Carvedilol 6.25mg Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 4x5x10

Price : ₹84/-

Cardistep 6.25 Tablet contains Carvedilol 6.25 mg, a beta-blocker used for the treatment of hypertension (high blood pressure), chronic heart failure, and angina (chest pain). It works by blocking beta-adrenergic receptors, leading to relaxation of blood vessels, reduced heart rate, and improved blood flow, which helps in managing cardiovascular conditions. By decreasing the workload on the heart, it enhances heart function and prevents complications such as heart attacks, strokes, and kidney damage.

This medication is particularly effective for patients with chronic heart failure, as it improves heart efficiency and reduces symptoms like fatigue, breathlessness, and fluid retention. It is also beneficial in post-heart attack recovery, as it helps stabilize heart function and prevents further damage. Carvedilol possesses antioxidant properties, which contribute to the protection of heart tissues and overall cardiovascular health.

In patients with hypertension, Cardistep 6.25 lowers blood pressure by reducing resistance in blood vessels, thereby reducing the risk of heart-related complications. Additionally, it is prescribed for angina, as it enhances blood supply to the heart and prevents episodes of chest pain.

Cardistep 6.25 Tablet should be taken as directed by a healthcare professional. Abrupt discontinuation of this medication can cause severe fluctuations in blood pressure and heart rate, so any dosage adjustments should be done under medical supervision. Patients should monitor their blood pressure and heart rate regularly while on this medication.

Read More

About the Product

Cardistep 6.25 Tablet contains Carvedilol 6.25 mg, a beta-blocker used for the treatment of hypertension (high blood pressure), chronic heart failure, and angina (chest pain). It works by blocking beta-adrenergic receptors, leading to relaxation of blood vessels, reduced heart rate, and improved blood flow, which helps in managing cardiovascular conditions. By decreasing the workload on the heart, it enhances heart function and prevents complications such as heart attacks, strokes, and kidney damage.

This medication is particularly effective for patients with chronic heart failure, as it improves heart efficiency and reduces symptoms like fatigue, breathlessness, and fluid retention. It is also beneficial in post-heart attack recovery, as it helps stabilize heart function and prevents further damage. Carvedilol possesses antioxidant properties, which contribute to the protection of heart tissues and overall cardiovascular health.

In patients with hypertension, Cardistep 6.25 lowers blood pressure by reducing resistance in blood vessels, thereby reducing the risk of heart-related complications. Additionally, it is prescribed for angina, as it enhances blood supply to the heart and prevents episodes of chest pain.

Cardistep 6.25 Tablet should be taken as directed by a healthcare professional. Abrupt discontinuation of this medication can cause severe fluctuations in blood pressure and heart rate, so any dosage adjustments should be done under medical supervision. Patients should monitor their blood pressure and heart rate regularly while on this medication.

May cause dizziness, fatigue, low blood pressure, slow heart rate, nausea, and cold extremities in some individuals.

Used for hypertension, chronic heart failure, and angina to improve heart function and reduce cardiovascular risks.

Do not stop taking this medication suddenly. Consult your doctor for proper dosage adjustments, especially if you have diabetes, liver disorders, or asthma.

Store in a cool, dry place, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation